Lessons from the E-SIRIUS trial

Italian Heart Journal

Volumn 5, Issue 1, 2004, Pages 1-2

  Schofer, Joachim ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; RAPAMYCIN;

ANGIOCARDIOGRAPHY; BLOOD VESSEL TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; EDITORIAL; HUMAN; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; HUMANS; RANDOMIZED CONTROLLED TRIALS; SIROLIMUS; STENTS;

EID: 7044272492     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (7)

1. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996; 94: 1247-54.
2. Morice MC, Serruys PW, Sousa JE, et al, for the RAVEL Study Group. A randomized comparison of a sirolimuseluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-80.
3. Colombo A, Drzewiecki J, Banning A, et al, for the TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788-94.
4. Moses JW, Leon MB, Popma JJ, et al, for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-23.
5. Schofer J, Schlüter M, Gershlick AH, et al, for the E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS). Lancet 2003; 362: 1093-9.
6. Schofer J, Breithardt G, Gershlick AH. Nine-month subgroup analysis of the E-SIRIUS trial: direct stenting vs predilation. (abstr) Circulation 2003; 108 (Suppl): IV-533.
7. Stone GW, Ellis SG, Cox DA, et al, for the TAXUS IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-31.